 |
|
Medication non-adherence in inflammatory bowel diseases is associated with disability
Jonathan Perry, Andy Chen, Viraj Kariyawasam, Glen Collins, Chee Choong, Wei Ling Teh, Nikola Mitrev, Friedbert Kohler, Rupert Wing Loong Leong
Intest Res. 2018;16(4):571-578. Published online 2018 Oct 10 DOI: https://doi.org/10.5217/ir.2018.00033
|
|
Citations to this article as recorded by
 Attitudes to medication and effects of IBD nursing service among patients with inflammatory bowel disease in Taiwan
Chen‐Ta Yang, Tsui‐Chun Hsu, Yang‐Yuan Chen, Siou‐Ping Huang, Hsu‐Heng Yen
Advances in Digestive Medicine.2024;[Epub] CrossRef COMPLIANCE AND QUALITY OF LIFE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES
R.J. JAMOLOVA, D.K. MUKHABBATOV, D.T. RAKHMONOV, S.G. ALI-ZADE
AVICENNA BULLETIN.2024; 26(1): 76. CrossRef High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease
Esma H. San, Angelique Egberts, Caroline W. Th. van Dijck - van Boetzelaer, Rachel L. West, Erwin C. Vasbinder
European Journal of Clinical Pharmacology.2024;[Epub] CrossRef A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan
Yanfang Liu, Choo Hua Goh, Hong Qiu, Kuan-Chih Huang, Hsingwen Chung, Carine Saadoun
Annals of Pharmacotherapy.2023; 57(9): 1053. CrossRef Development and implementation of a laboratory monitoring dashboard to reduce treatment gaps in inflammatory bowel disease
Miranda Kozlicki, Bridget Lynch, Tony Donoho, Patrick Nichols, Autumn D Zuckerman
American Journal of Health-System Pharmacy.2023; 80(Supplement): S55. CrossRef Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease
Edward V. Loftus, Jenny Griffith, Ezequiel Neimark, Alexandra Song, Kori Wallace, Sujani Nannapaneni, Ji Zhou, Rachel Byrne, Kristina Kligys, Yinuo Pang, Xiaomei Liao, Jasmina Kalabic, Marla Dubinsky
Advances in Therapy.2023; 40(5): 2311. CrossRef Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel Disease
Ashkan Rezazadeh Ardabili, Dirk van Esser, Dion Wintjens, Mia Cilissen, Debbie Deben, Zlatan Mujagic, Fritzi Russ, Laurents Stassen, Adriaan A Van Bodegraven, Dennis Wong, Bjorn Winkens, Daisy Jonkers, Mariëlle Romberg-Camps, Marie J Pierik
Journal of Crohn's and Colitis.2023; 17(7): 1079. CrossRef Factors contributing to flares of ulcerative colitis in North India- a case-control study
Vishavdeep Singh Rana, Gaurav Mahajan, Amol N. Patil, Anupam K. Singh, Vaneet Jearth, Aravind Sekar, Harjeet Singh, Atul Saroch, Usha Dutta, Vishal Sharma
BMC Gastroenterology.2023;[Epub] CrossRef An education‐based telehealth group improves the management and clinical outcomes of patients with inflammatory bowel disease in China (THEIM study)
Jian Kang, Juan Su, Jing Wang, Haixia Ren, Anning Yin, Jiao Li, Qian Zhou, Yang Wang, Peng Zhu, Liping Zou, Wei Wang, Zhishun Tang, Weiguo Dong, Yijuan Ding, Ping An
United European Gastroenterology Journal.2023; 11(10): 960. CrossRef Understanding Medication Nonadherence in Crohn’s Disease Patients: A Qualitative Evaluation
Robert E Brady, Jessica K Salwen-Deremer, Natalie C Tunnell, Michael W Winter
Inflammatory Bowel Diseases.2023;[Epub] CrossRef Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening
Zohar Ben-Shatach, Tomer Ziv-Baran, Ella Fudim, Miri Yavzori, Orit Picard, Asaf Levartovsky, Limor Selinger, Batia Weiss, Uri Kopylov, Rami Eliakim, Bella Ungar
Therapeutic Advances in Gastroenterology.2022; 15: 175628482210833. CrossRef Medication Adherence and Its Influencing Factors Among Inflammatory Bowel Disease Patients in China
Fen Xu, Juping Tang, Zhiping Zhu, Yan Chen, Wen Hu, Sha Lu, Yunxian Zhou, Ding Lin
International Journal of General Medicine.2022; Volume 15: 4141. CrossRef Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn’s Disease Initiated on Biologic or Conventional Agents
Dominic Pilon, Zhijie Ding, Erik Muser, Ameur M Manceur, Maude Vermette-Laforme, Marie-Hélène Lafeuille, Patrick Lefebvre
Crohn's & Colitis 360.2022;[Epub] CrossRef Medication adherence in women with IBD of childbearing age likely associated with disease knowledge
Robyn Laube, Christian Selinger, Rupert W. Leong
Therapeutic Advances in Gastroenterology.2022; 15: 175628482211440. CrossRef Utility of the MARS-5 in Assessing Medication Adherence in IBD
James K Stone, Leigh Anne Shafer, Lesley A Graff, Lisa Lix, Kelcie Witges, Laura E Targownik, Clove Haviva, Kathryn Sexton, Charles N Bernstein
Inflammatory Bowel Diseases.2021; 27(3): 317. CrossRef Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes
Chikako Watanabe, Masakazu Nagahori, Toshimitsu Fujii, Kaoru Yokoyama, Naoki Yoshimura, Taku Kobayashi, Hirokazu Yamagami, Kazuya Kitamura, Kagaya Takashi, Shiro Nakamura, Makoto Naganuma, Shunji Ishihara, Motohiro Esaki, Maria Yonezawa, Reiko Kunisaki, A
Digestive Diseases and Sciences.2021; 66(2): 577. CrossRef Selected psychological predictors of medication adherence in the older adults with chronic diseases
Magdalena Gruszczyńska, Julia Wyszomirska, Anna Daniel‐Sielańczyk, Monika Bąk‐Sosnowska
Nursing Open.2021; 8(1): 317. CrossRef Impacto de la pandemia covid-19 en la adherencia al tratamiento en pacientes con enfermedad inflamatoria intestinal: experiencia de un centro terciario en Chile
Rodrigo Quera, Daniela Simian, Lilian Flores, Patricio Ibáñez, Carolina Figueroa
Gastroenterología y Hepatología.2021; 44(9): 654. CrossRef Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: a systematic review
Juan C Nieto, Claudia Arajol, Loreto Carmona, Carlos Marras, Luis Cea-Calvo
Immunotherapy.2021; 13(5): 433. CrossRef Researching Interventions to Improve Medication Adherence in Ulcerative Colitis Patients
Mila Palma Pacheco, Flora Maria Lorenzo Fortes, Raquel Rocha dos Santos, Genoile Oliveira Santana Silva
Journal of Coloproctology.2021; 41(01): 096. CrossRef Persistence as a Robust Indicator of Medication Adherence-Related Quality and Performance
Enrica Menditto, Caitriona Cahir, Sara Malo, Isabel Aguilar-Palacio, Marta Almada, Elisio Costa, Anna Giardini, María Gil Peinado, Mireia Massot Mesquida, Sara Mucherino, Valentina Orlando, Carlos Luis Parra-Calderón, Enrique Pepiol Salom, Przemyslaw Kard
International Journal of Environmental Research and Public Health.2021; 18(9): 4872. CrossRef Effect of point‐of‐care gastrointestinal ultrasound on decision‐making and management in inflammatory bowel disease
Antony B. Friedman, Anil Asthana, Simon R. Knowles, Aphra Robbins, Peter R. Gibson
Alimentary Pharmacology & Therapeutics.2021; 54(5): 652. CrossRef Impact of the COVID-19 pandemic on treatment adherence in patients with inflammatory bowel disease: Experience of a tertiary hospital in Chile
Rodrigo Quera, Daniela Simian, Lilian Flores, Patricio Ibáñez, Carolina Figueroa
Gastroenterología y Hepatología (English Edition).2021; 44(9): 654. CrossRef Adherence to treatment in patients with inflammatory bowel disease
K. A. Andreev, A. V. Gorbenko, Yu. P. Skirdenko, N. A. Nikolaev, M. A. Livzan, G. R. Bikbavova, M. M. Fedorin
Bulletin of Siberian Medicine.2021; 20(3): 120. CrossRef Treatment Adherence in Inflammatory Bowel Disease Patients from Argentina: A Multicenter Study
Juan Lasa, Gustavo Correa, Claudia Fuxman, Laura Garbi, Maria Eugenia Linares, Pablo Lubrano, Astrid Rausch, Martin Toro, Martin Yantorno, Ignacio Zubiaurre, Laurent Peyrin-Biroulet, Pablo Olivera
Gastroenterology Research and Practice.2020; 2020: 1. CrossRef Knowledge of disease and self‐management of adolescents with inflammatory bowel diseases
Alex Krauthammer, Tal Harel, Noam Zevit, Dror S. Shouval, Raanan Shamir, Batia Weiss
Acta Paediatrica.2020; 109(10): 2119. CrossRef The burden of cost in inflammatory bowel disease: a medical economic perspective
Jonathan A. Beard, Benjamin H. Click
Current Opinion in Gastroenterology.2020; 36(4): 310. CrossRef İnflamatuar Bağırsak Hastalıkları Olan Bireylerde İlaç Uyumu ve Yaşam Kalitesi
Nazli ÖZTÜRK, Yasemin YILDIRIM
Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi.2020; 2(3): 192. CrossRef Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus
Marco Daperno, Alessandro Armuzzi, Silvio Danese, Walter Fries, Giuseppina Liguori, Ambrogio Orlando, Claudio Papi, Mariabeatrice Principi, Fernando Rizzello, Angelo Viscido, Paolo Gionchetti
Gastroenterology Research and Practice.2019; 2019: 1. CrossRef The Development of a Screening Tool to Identify and Classify Nonadherence in Inflammatory Bowel Disease
Aria Zand, Audrey Nguyen, Zack Stokes, Welmoed van Deen, Courtney Reynolds, Magdalena Dimitrova, Ariela Khandadash, Miriam Dvorsky, Jenny Sauk, Eric Esrailian, Daniel Hommes
Crohn's & Colitis 360.2019;[Epub] CrossRef Adherence to therapy of patients with inflammatory bowel diseases
A I Parfenov, A V Kagramanova, A F Babayan, O V Knyazev
Terapevticheskii arkhiv.2018; 90(12): 4. CrossRef
|